TY - JOUR
T1 - World allergy organization guidelines for prevention of allergy and allergic asthma
AU - Asher, Innes
AU - Baena-Cagnani, Carlos
AU - Boner, Attilio
AU - Canonica, G. Walter
AU - Chuchalin, Alexander
AU - Custovic, Adnan
AU - Dagli, Elif
AU - Haahtela, Tari
AU - Haus, Matthias
AU - Hemmo-Loten, Michal
AU - Holgate, Stephen
AU - Holloway, John
AU - Holt, Patrick
AU - Host, Arne
AU - Iikura, Yoji
AU - Johansson, S. G.O.
AU - Kaplan, Allen
AU - Kowalski, Marek L.
AU - Lockey, Richard
AU - Naspitz, Charles
AU - Odhiambo, Joseph
AU - Ring, Johannes
AU - Sastre, Joaquin
AU - Schäfer, Torsten
AU - Venables, Katherine
AU - Vichyanond, Pakit
AU - Volovitz, Benjamin
AU - Wahn, Ulrich
AU - Warner, John
AU - Weiss, Kevin
AU - Zhong, Nan Shan
AU - Henley, Karen
PY - 2004/9
Y1 - 2004/9
N2 - The prevalence of asthma and allergy is increasing. It is estimated that over 20% of the world's population suffer from immunoglobulin E (IgE)-mediated allergic diseases such as asthma, rhinoconjunctivitis, eczema, and anaphylaxis. Asthma, which in more than 50% of adults and in at least 80% of affected children is allergic, occurs in around 5-15% of the pediatric population. Asthma is estimated by the World Health Organization (WHO) to affect 150 million people worldwide, placing an enormous strain on health resources in many countries, and is a major cause of hospitalizations for chronic diseases in children in the western world. Prevention of Allergy and Allergic Asthma was a collaborative project between the World Allergy Organization (WAO) and the World Health Organization (WHO) [1]. This document is a condensed version of the full Prevention of Allergy and Allergic Asthma Report [2]. The strategic guidelines in this document have been developed to provide a sound basis for practical action to be taken by governments, health care professionals, lay organizations, and patients.
AB - The prevalence of asthma and allergy is increasing. It is estimated that over 20% of the world's population suffer from immunoglobulin E (IgE)-mediated allergic diseases such as asthma, rhinoconjunctivitis, eczema, and anaphylaxis. Asthma, which in more than 50% of adults and in at least 80% of affected children is allergic, occurs in around 5-15% of the pediatric population. Asthma is estimated by the World Health Organization (WHO) to affect 150 million people worldwide, placing an enormous strain on health resources in many countries, and is a major cause of hospitalizations for chronic diseases in children in the western world. Prevention of Allergy and Allergic Asthma was a collaborative project between the World Allergy Organization (WAO) and the World Health Organization (WHO) [1]. This document is a condensed version of the full Prevention of Allergy and Allergic Asthma Report [2]. The strategic guidelines in this document have been developed to provide a sound basis for practical action to be taken by governments, health care professionals, lay organizations, and patients.
KW - Allergy
KW - Asthma
KW - Education
KW - Prevention
KW - Strategy
UR - http://www.scopus.com/inward/record.url?scp=5044230484&partnerID=8YFLogxK
U2 - 10.1027/0838-1925.16.5.176
DO - 10.1027/0838-1925.16.5.176
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:5044230484
SN - 0838-1925
VL - 16
SP - 176
EP - 185
JO - Allergy and Clinical Immunology International
JF - Allergy and Clinical Immunology International
IS - 5
ER -